• 1
    Adachi, S., Kubota, M., Akiyama, Y., Kato, T., Kitoh, T., Furusho, K. (1997) Successful bone marrow transplantation from an HLA-identical unrelated donor in a patient with hemophagocytic lymphohistiocytosis. Bone Marrow Transplantation, 19, 183 185.
  • 2
    Ambruso, D.R., Hays, T., Zwartjes, W.J., Tubergen, D.G., Favara, B.E. (1980) Successful treatment of lymphohistiocytic reticulosis with phagocytosis with epipodophyllotoxin VP 16-213. Cancer, 45, 2516 2520.
  • 3
    Aricò, M., Janka, G., Fischer, A., Henter, J-I., Blanche, S., Elinder, G., Martinetti, M., Rusca, M.P. (1996) Hemophagocytic lymphohistiocytosis: report of 122 children from the international registry. Leukemia, 10, 197 203.
  • 4
    Baker, K.S., DeLaat, C.A., Steinbuch, M., Gross, T.G., Shapiro, R.S., Loechelt, B., Harris, R., Filipovich, A.H. (1997) Successful correction of hemophagocytic lymphohistiocytosis with related or unrelated bone marrow transplantation. Blood, 89, 3857 3863.
  • 5
    Bearman, S.I., Appelbaum, F.R., Buckner, C.D., Petersen, F., Fisher, L.D., Clift, R.A., Thomas, E.D. (1988) Regimen-related toxicity in patients undergoing bone marrow transplantation. Journal of Clinical Oncology, 6, 1562 1568.
  • 6
    Beelen, D.W., Haralambie, E., Brandt, H., Linzenmeier, G., Müller, K.D., Quabeck, K., Sayer, H.G., Graeven, U., Mahmoud, H.K., Schaefer, U.W. (1992) Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation. Blood, 80, 2668 2676.
  • 7
    Bolme, P., Henter, J-I., Winiarski, J., Elinder, G., Ljungman, P., Lönnerholm, G., Ringdén, O. (1995) Allogeneic bone marrow transplantation for hemophagocytic lymphohistiocytosis in Sweden. Bone Marrow Transplantation, 15, 331 335.
  • 8
    Brown, R.E., Bowman, W.P., D'Cruz, C.A., Pick, T.E., Champion, J.E. (1987) Endoperoxidation, hyperprostaglandinemia, and hyperlipidemia in a case of erythrophagocytic lymphohistiocytosis: reversal with VP-16 and indomethacin. Cancer, 60, 2388 2393.
  • 9
    Eife, R., Janka, G.E., Belohradsky, B.H., Holtmann, H. (1989) Natural killer cell function and interferon production in familial hemophagocytic lymphohistiocytosis. Pediatric Hematology and Oncology, 6, 265 272.
  • 10
    Farquhar, J.W. & Claireaux, A.F. (1952) Familial hemophagocytic reticulosis. Archives of Disease in Childhood, 27, 519 525.
  • 11
    Fischer, A., Virelizier, J.L., Arenzana-Seisdedos, F., Perez, N., Nezelof, C., Criscelli, C. (1985) Treatment of four patients with erythrophagocytic lymphohistiocytosis by a combination of epipodophyllotoxin, steroids, intrathecal methotrexate, and cranial irradiation. Pediatrics, 76, 263 268.
  • 12
    Fischer, A., Cerf-Bensussan, N., Blanche, S., Le Deist, F., Bremard-Oury, C., Leverger, G., Schaison, G., Durandy, A., Griscelli, C. (1986) Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. Journal of Pediatrics, 108, 267 270.
  • 13
    Glucksberg, H., Storb, R., Fefer, A., Buckner, C., Neiman, P., Clift, R., Lerner, K., Thomas, E. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched donors. Transplantation, 18, 295 304.
  • 14
    Haddad, E., Sulis, M.L., Jabado, N., Blanche, S., Fischer, A., Tardieu, M. (1997) Frequency and severity of central nervous system lesions in hemophagocytic lymphohistiocytosis. Blood, 89, 794 800.
  • 15
    Henter, J.I., Elinder, G., Finkel, Y., Soder, O. (1986) Successful induction with chemotherapy including teniposide in familial erytrophagocytic lymphohistiocytosis. Lancet, ii, 1402.
  • 16
    Henter, J.I., Elinder, G., Ost, A. (1991 a) Diagnostic guidelines for hemophagocytic lymphohistiocytosis. The FHL study group of the Histiocyte Society. Seminars in Oncology, 18, 29 33.
  • 17
    Henter, J-I., Elinder, G., Söder, O., Hansson, M., Andersson, B., Andersson, U. (1991 b) Hypercytokinemia in familial hemophagocytic lymphohistiocytosis. Blood, 78, 2918 2922.
  • 18
    Hirst, W.J.R., Layton, K.M., Singh, S., Mieli-Vergani, G., Chessells, J.M., Strobel, S., Pritchard, J. (1994) Haemophagocytic lymphohistiocytosis: experience at two U.K. centres. British Journal of Haematology, 88, 731 739.
  • 19
    Imashuku, S. & Hibi, S. (1991) Cytokines in haemophagocytic syndrome. British Journal of Haematology, 77, 438 440.
  • 20
    Jabado, N., De Graeff-Meeder, E.R., Cavazzana-Calvo, M., Haddad, E., Le Deist, F., Benkerrou, M., Dufourcq, R., Caillat, S., Blanche, S., Fischer, A. (1997) Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors. Blood, 90, 4743 4748.
  • 21
    Janka, G.E. (1983) Familial hemophagocytic lymphohistiocytosis. European Journal of Pediatrics, 140, 221 230.
  • 22
    Ladisch, S., Ho, W., Matheson, D., Pilkington, R., Hartman, G. (1982) Immunologic and clinical effects of repeated blood exchange in familial erythrophagocytic lymphohistiocytosis. Blood, 60, 814 821.
  • 23
    Landman-Parker, J., Le Deist, F., Blaise, A., Brison, O., Fischer, A. (1993) Partial engraftment of donor bone marrow cells associated with long-term remission of haemophagocytic lymphohistiocytosis. British Journal of Haematology, 85, 37 41.
  • 24
    McDonald, G.B., Hinds, M.S., Fisher, L.D., Schoch, H.G., Wolford, J.L., Banaji, M., Hardin, B.J., Shulman, H.M., Clift, R.A. (1993) Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Annals of Internal Medicine, 118, 255 267.
  • 25
    Méresse, V., Hartmann, O., Vassal, G., Benhamou, E., Valteau-Couanet, D., Brugieres, L., Lemerle, J. (1992) Risk factors for hepatic veno-occlusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplantation, 10, 135 141.
  • 26
    Perez, N., Virelizier, J-L., Arenzana-Seisdedos, F., Fischer, A., Griscelli, C. (1984) Impaired natural killer cell activity in lymphohistiocytosis syndrome. Journal of Pediatrics, 104, 569 573.
  • 27
    Poynton, C.H., Jackson, S., Fegan, C., Barnes, R.A., Whittaker, J.A. (1992) Use of IgM enriched intravenous immunoglobulin (Pentaglobin) in bone marrow transplantation. Bone Marrow Transplantation, 9, 451 457.
  • 28
    Schneider, E.M., Pawelec, G., Shi, L.R., Wernet, P. (1984) A novel type of human T cell clones with highly potent natural killer-like cytotoxicity divorced from large granular lymphocyte morphology. Journal of Immunology, 133, 173 179.
  • 29
    Schipper, R.F., D'Amaro, J., Oudshoorn, M. (1996) The probability of finding a suitable related donor for bone marrow transplantation in extended families. Blood, 87, 800 804.
  • 30
    Shulman, H., Sullivan, K., Widen, P., McDonald, G., Striker, G., Sale, G., Hackman, R., Tsoi, M., Storb, R., Thomas, E. (1980) Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. American Journal of Medicine, 69, 204 217.
  • 31
    Stéphan, J.L., Donadieu, J., Ledeist, F., Blanche, S., Griscelli, C., Fischer, A. (1991) Treatment of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins, steroids, and cyclosporin A. Blood, 82, 2319 2323.
  • 32
    Stockschläder, M., Löliger, C., Krüger, W., Zeller, W., Heyll, A., Schönrock-Nabulsi, P., Zander, A. (1995) Transplantation of allogeneic rhG-CSF mobilized peripheral CD34+ cells from an HLA-identical unrelated donor. Bone Marrow Transplantation, 16, 719 722.
  • 33
    Storb, R., Deeg, H.J., Farewell, V., Doney, K., Appelbaum, F., Beatty, P., Bensinger, W., Buckner, C.D., Clift, R., Hansen, J., Hill, R., Longton, G., Lum, L., Martin, P., McGuffin, R., Sanders, J., Singer, J., Stewart, P., Sulivan, K., Witherspoon, R., Thomas, E.D. (1986) Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood, 68, 119 125.
  • 34
    Ware, R., Friedman, H.S., Kinney, T.R., Kurtzberg, J., Chaffee, S., Falletta, J.M. (1990) Familial erythrophagocytic lymphohistiocytosis: late relapse despite continuous high-dose VP-16 chemotherapy. Medical and Pediatric Oncology, 18, 27 29.